Short Description Einstein professor identifying chaperone‑mediated autophagy in aging.
Description Dr. Ana Maria Cuervo co‑discovered LAMP2A as the rate‑limiting receptor for chaperone‑mediated autophagy (CMA) and showed CMA decline drives neurodegeneration and metabolic disease. She directs the Institute for Aging Research’s NIH‑funded Autophagy Program and collaborates with pharma on CMA‑enhancing small molecules. Cuervo educates the Hispanic community on healthy aging and mentors under‑represented students in biomedicine.